Acute onset of nephrotic syndrome during interferon-α retreatment for chronic active hepatitis C

Journal of Gastroenterology

Volumn 37, Issue 10, 2002, Pages 854-858

  Nishimura, Satoshi ^a   Miura, Hideaki ^a   Yamada, Haruki ^a   Shinoda, Toshio ^a   Kitamura, Shigehiro ^a   Miura, Yasasuda ^a  

^a Social Insurance Central General Hospital   (Japan)

Author keywords

Chronic hepatitis C; Cytokines; Interferon retreatment; Interstitial nephritis; Minimal change; Nephrotic syndrome; Recombinant interferon

Indexed keywords

ALBUMIN; AMPICILLIN; ANTIBIOTIC AGENT; COMPLEMENT; IMMUNOGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON; TUBERCULOSTATIC AGENT; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG WITHDRAWAL; EDEMA; ELECTRON MICROSCOPY; FEMALE; GLOMERULUS EPITHELIUM; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY INTERSTITIUM; LYMPHOID CELL; MOON FACE; NEEDLE BIOPSY; NEPHROTIC SYNDROME; OBESITY; OLIGURIA; PRIORITY JOURNAL; PROTEINURIA; RETREATMENT; SHOCK; TUBERCULOUS PLEURISY; VERTIGO;

ACUTE DISEASE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; MIDDLE AGED; NEPHROTIC SYNDROME; RETREATMENT;

EID: 0036812372     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200141     Document Type: Article

References (24)

1. Ault BH, Stapleton FB, Gaber L, Martin A, Roy S 3rd, Murphy SB. Acute renal failure during therapy with recombinant human gamma interferon. N Engl J Med 1998;319:1397-400.
2. Dimitrov Y, Heibel F, Marcelliin L, Chantrel F, Moulin B, Hannedouche T. Acute renal failure and nephrotic syndrome with alpha interferon therapy. Nephrol Dial Transplant 1997;12: 200-3.
3. Rettmar K, Kienast J, van de Loo J. Minimal change glomerulonephritis with reversible proteinuria during interferon-α2a therapy for chronic myeloid leukemia. Am J Hematol 1995;49: 355-6.
4. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU. Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 1986;4:234-43.
5. Sherwin SA, Knost JA, Fein S, Abrams PG, Foon KA, Ochs JJ, et al. A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients. JAMA 1982;248:2461-6.
6. Phillips TM. Interferon-α induces renal dysfunction and injury. Curr Opin Nephrol Hypertens. 1996;5:380-3.
7. Horino T, Kuriyama S, Tomonari H, Numata M, Hayashi F, Nagata H, et al. Renal damage in a chronic active hepatitis C patient receiving interferon-α therapy (in Japanese with English abstract). Jpn J Nephrol 1998;40:48-53.
8. Coroneos E, Petrusevska G, Varghese F, Truong LD. Focal segmental glomerulosclerosis with acute renal failure associated with α-interferon therapy. Am J Kidney Dis 1996;28:886-92.
9. Traynor A, Kuzel T, Samuelson E, Kanwar Y. Minimal-change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma. Nephron 1994;67:94-100.
10. Tashiro M, Yokoyama K, Nakayama M, Yamada A, Ogura Y, Kawaguchi Y, et al. A case of nephrotic syndrome developing during postoperative gamma interferon therapy for renal cell carcinoma. Nephron 1996;83:685-8.
11. Averbuch SD, Austin HA 3rd, Sherwin SA, Antonovych T, Bunn PA Jr, Longo DL. Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte A interferon therapy for mycosis fungoides. N Engl J Med 1984;310:32-5.
12. Kimmel PL, Abraham AA, Phillips TM. Membranoproliferative glomerulonephritis in a patient treated with interferon-α for human immunodeficiency virus infection. Am J Kidney Dis 1994;24:858-63.
13. Kuramoto I, Fujiyama S, Chikazawa H, Izumo K, Gohsi K, Iida S, et al. Analysis of proteinuria in the patients with chronic hepatitis during the interferon therapy (in Japanese with English abstract). Acta Hepatol Jap 1992;33:517-23.
14. Finkelstein A, Fraley DS, Stachura I, Feldman HA, Gandy DR, Bourke E. Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis: a possible T-lymphocyte disorder. Am J Med 1982;72:81-7.
15. Baum M, Piel CF, Goodman JR. Antibiotic-associated interstitial nephritis and nephrotic syndrome. Am J Nephrol 1986;6:149-51.
16. Kobayashi M, Chayama K, Arase Y, Tsubota A, Suzuki Y, Saitoh S, et al. The non-effect of anti-interferon alpha-2a antibody on the response to interferon therapy (in Japanese with English abstract). Acta Hepatol Japon 1996;37:208-13.
17. Morel-Maroger L, Sloper JC, Vinter J, Woodrow D, Gresser I. An ultrastructural study of the development of nephritis in mice treated with interferon in the neonatal period. Lab Invest 1978;39:513-22.
18. Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M. Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 1991;68:1536-7.
19. Andres GA, Spiele H, McCluskey RT. Virus-like structures in systemic lupus erythematosus. Prog Clin Immunol 1972;1:23-44.
20. Churchwell MA, Noah PW, Rosenberg EW, Bale G, Brown PS, Pitcock JA, et al. Electron microscopic detection of virus particles in the rhino mouse. Am J Med Sci 1986;291:314-20.
21. Nagata S, Tsuchiya M, Asano S, Yamamoto O, Hirata Y, Kubota N, et al. The chromosomal gene structure and two mRNAs for human granulocyte colony-stimulating factor. EMBO J 1986;5: 575-81.
22. Peces R, de la Torre M, Alcazar R, Urra JM. Antibodies against recombinant human erythropoietin in a patient with erythropoietin-resistant anemia. N Engl J Med 1996;335:523-4.
23. Menne T, Dodd NJ, Williams P, Casadevall N, Orfali KA, Gordon-Smith EC. Acquired pure red cell aplasia due to treatment induced erythropoietin antibodies. Br J Haematol 2000;108 (Suppl 1):37.
24. Prabhakar SS, Muhlfelder T. Antibodies to recombinant human erythropoietin causing pure red cell aplasia. Clin Nephrol 1997;47: 331-5.